5.23.23 | Maternal Health Maternal Health Network Meeting Addresses Novel Approaches for Education About Prenatal Genetic Screening
In a Maternal Health Network meeting, Katie Stoll, MS, LGC, executive director of the Genetic Support Foundation (GSF), shared about educational and decision support tools for prenatal testing.
5.16.23 | Policy SWHR Endorses “Momnibus 2.0”
SWHR is pleased to once again offer its endorsement of the Black Maternal Health Momnibus Act (or Momnibus Act).
2.2.23 | Endometriosis VCU Health of Women 2023 | Emerging Topics in Women’s Health: A Focus on Uterine Health
For more than 30 years, the Society for Women’s Health Research (SWHR) has led interdisciplinary groups of researchers, health care […]
1.18.23 | Maternal Health PRGLAC Then and Now: Where We Are and Where We’re Going
During this congressional briefing and national webinar, designed specifically for—but not limited to—members of the 118th Congress, panelists reviewed the state of PRGLAC, the PRGLAC recommendations and their implementation status and the current legislative and regulatory landscape.
1.5.23 | Maternal Health Pregnant and Lactating Populations in Research: How Leaving These Populations Out Leaves Them Behind
During this congressional briefing and national webinar, panelists explored certain areas of research where the exclusion of these groups has resulted in an inability to support them, how federal research investments could improve outcomes, and where there is opportunity—both at the legislative and regulatory level—moving forward.
12.13.22 | Policy Reps. Castor, Fitzpatrick, and Underwood Introduce Legislation to Promote Greater Inclusion of Pregnant and Lactating Women in Research
Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduced H.R. 9487, the Advancing Safe Medications for Moms and Babies Act of 2022 on December 13, 2022.
11.16.22 | Maternal Health NICHD’s Role in Advancing Research on Pregnant and Lactating Populations
Dr. Diana Bianchi gave remarks on NICHD’s role in advancing research in pregnant and lactating populations during an October meeting of the Coalition to Advance Maternal Therapeutics (CAMT).
11.8.22 | Maternal Health Addressing Concerns and Considerations Surrounding the Inclusion of Pregnant and Lactating Populations in Research
During this virtual congressional briefing and national webinar, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research, how to ensure the appropriate inclusion of these populations, and the current state of this type of inclusion in research, both within the federal government and the corporate sector.
9.9.22 | Genetic Screening Considering the Patient Experience in Noninvasive Prenatal Screening
Prenatal genetic screening can be a helpful tool for future parents to make informed decisions about their health care. SWHR spoke with two experts at the National Society of Genetic Counselors (NSGC) about genetic screening.
9.6.22 | Genetic Screening NIPS Explained: A Fireside Chat About Prenatal Genetic Screening
SWHR hosted a fireside chat to share educational information about the impact of prenatal screening on maternal and infant health. The event discussed how to reduce barriers to care and improve health outcomes through patient education, patient provider communication, and informed consent.
